AstraZeneca Records Bumper COVID-19 Vaccine Sales Of $4B In FY21 By: TalkMarkets February 10, 2022 at 07:19 AM EST Core earnings per share (EPS) came in at $1.67, topping estimates of $0.73. Read More >> Related Stocks: Astrazeneca Plc ADR